cardura
Generic: doxazosin
Labeler: viatris specialty llcDrug Facts
Product Profile
Brand Name
cardura
Generic Name
doxazosin
Labeler
viatris specialty llc
Dosage Form
TABLET
Routes
Active Ingredients
doxazosin mesylate 8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
58151-077
Product ID
58151-077_438349cb-eae0-43b5-b045-d447b1c9a376
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA019668
Listing Expiration
2027-12-31
Marketing Start
2025-04-23
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
58151077
Hyphenated Format
58151-077
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cardura (source: ndc)
Generic Name
doxazosin (source: ndc)
Application Number
NDA019668 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/1
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING CARDURA (doxazosin) is available as tablets for oral administration. Each tablet contains doxazosin mesylate equivalent to 1 mg (white), 2 mg (white), 4 mg (white) or 8 mg (white) of doxazosin as the free base. NDC and Pack Size Strength Description NDC 58151-074-01 (Bottle of 100) 1 mg White, round tablets with “CN1” on one side and “VLE” on the other side. NDC 58151-075-01 (Bottle of 100) 2 mg White, oblong tablets with score and “CN 2” on one side and “VLE” on the other side. NDC 58151-076-01 (Bottle of 100) 4 mg White, rhombus shaped tablets with break score and “CN 4” on one side and VLE on the other side. NDC 58151-077-01 (Bottle of 100) 8 mg White, capsule shaped tablets with break score and “CN 8” on one side and “VLE” on the other side. Recommended Storage: Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
- PRINCIPAL DISPLAY PANEL – 1 mg NDC 58151-074-01 Cardura ® (doxazosin) tablets 1 mg* 100 Tablets Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 1 mg doxazosin as a free base. Made in Germany Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2023 Viatris Inc. RUPJ074A Cardura (doxazosin) Tablets 1 mg Bottle Label
- PRINCIPAL DISPLAY PANEL – 2 mg NDC 58151-075-01 Cardura ® (doxazosin) tablets 2 mg* 100 Tablets Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 2 mg doxazosin as a free base. Made in Germany Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2023 Viatris Inc. RUPJ075A Cardura (doxazosin) Tablets 2 mg Bottle Label
- PRINCIPAL DISPLAY PANEL – 4 mg NDC 58151-076-01 Cardura ® (doxazosin) tablets 4 mg* 100 Tablets Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin as a free base. Made in Germany Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2023 Viatris Inc. RUPJ076A Cardura (doxazosin) Tablets 4 mg Bottle Label
- PRINCIPAL DISPLAY PANEL – 8 mg NDC 58151-077-01 Cardura® (doxazosin) tablets 8 mg* 100 Tablets Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 8 mg doxazosin as a free base. Made in Germany Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2023 Viatris Inc. RUPJ077A Cardura (doxazosin) Tablets 8 mg Bottle Label
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "438349cb-eae0-43b5-b045-d447b1c9a376", "openfda": {"upc": ["0358151074013"], "unii": ["86P6PQK0MU"], "rxcui": ["104367", "104368", "104369", "197625", "197626", "197627", "197628", "205544"], "spl_set_id": ["5e1f5e49-2da1-43ab-9795-228a8bcc5a82"], "manufacturer_name": ["Viatris Specialty LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Cardura", "product_id": "58151-077_438349cb-eae0-43b5-b045-d447b1c9a376", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "58151-077", "generic_name": "doxazosin", "labeler_name": "Viatris Specialty LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cardura", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "8 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA", "marketing_start_date": "20250423", "listing_expiration_date": "20271231"}